121 related articles for article (PubMed ID: 37502948)
1. High throughput PRIME editing screens identify functional DNA variants in the human genome.
Ren X; Yang H; Nierenberg JL; Sun Y; Chen J; Beaman C; Pham T; Nobuhara M; Takagi MA; Narayan V; Li Y; Ziv E; Shen Y
bioRxiv; 2023 Jul; ():. PubMed ID: 37502948
[TBL] [Abstract][Full Text] [Related]
2. High-throughput PRIME-editing screens identify functional DNA variants in the human genome.
Ren X; Yang H; Nierenberg JL; Sun Y; Chen J; Beaman C; Pham T; Nobuhara M; Takagi MA; Narayan V; Li Y; Ziv E; Shen Y
Mol Cell; 2023 Dec; 83(24):4633-4645.e9. PubMed ID: 38134886
[TBL] [Abstract][Full Text] [Related]
3. MOSAIC enables
Hsu JY; Lam KC; Shih J; Pinello L; Joung JK
bioRxiv; 2024 Apr; ():. PubMed ID: 38712243
[TBL] [Abstract][Full Text] [Related]
4. Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants.
Sánchez-Rivera FJ; Diaz BJ; Kastenhuber ER; Schmidt H; Katti A; Kennedy M; Tem V; Ho YJ; Leibold J; Paffenholz SV; Barriga FM; Chu K; Goswami S; Wuest AN; Simon JM; Tsanov KM; Chakravarty D; Zhang H; Leslie CS; Lowe SW; Dow LE
Nat Biotechnol; 2022 Jun; 40(6):862-873. PubMed ID: 35165384
[TBL] [Abstract][Full Text] [Related]
5. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
Sahu S; Sullivan TL; Mitrophanov AY; Galloux M; Nousome D; Southon E; Caylor D; Mishra AP; Evans CN; Clapp ME; Burkett S; Malys T; Chari R; Biswas K; Sharan SK
PLoS Genet; 2023 Sep; 19(9):e1010940. PubMed ID: 37713444
[TBL] [Abstract][Full Text] [Related]
6. Approaches for the sensitive detection of rare base and prime editing events.
Nguyen Tran MT; Rajendra KC; Patterson FM; Liu GS; Cook AL; Hewitt AW
Methods; 2021 Oct; 194():75-82. PubMed ID: 33484827
[TBL] [Abstract][Full Text] [Related]
7. High-throughput evaluation of genetic variants with prime editing sensor libraries.
Gould SI; Wuest AN; Dong K; Johnson GA; Hsu A; Narendra VK; Atwa O; Levine SS; Liu DR; Sánchez Rivera FJ
Nat Biotechnol; 2024 Mar; ():. PubMed ID: 38472508
[TBL] [Abstract][Full Text] [Related]
8. Massively parallel assessment of human variants with base editor screens.
Hanna RE; Hegde M; Fagre CR; DeWeirdt PC; Sangree AK; Szegletes Z; Griffith A; Feeley MN; Sanson KR; Baidi Y; Koblan LW; Liu DR; Neal JT; Doench JG
Cell; 2021 Feb; 184(4):1064-1080.e20. PubMed ID: 33606977
[TBL] [Abstract][Full Text] [Related]
9. Regional Variation in Cardiovascular Genes Enables a Tractable Genome Editing Strategy.
Krysov VA; Wilson RH; Ten NS; Youlton N; De Jong HN; Sutton S; Huang Y; Reuter CM; Grove ME; Wheeler MT; Ashley EA; Parikh VN
Circ Genom Precis Med; 2024 Apr; 17(2):e004370. PubMed ID: 38506054
[TBL] [Abstract][Full Text] [Related]
10. Saturation editing of genomic regions by multiplex homology-directed repair.
Findlay GM; Boyle EA; Hause RJ; Klein JC; Shendure J
Nature; 2014 Sep; 513(7516):120-3. PubMed ID: 25141179
[TBL] [Abstract][Full Text] [Related]
11. Automated design of CRISPR prime editors for 56,000 human pathogenic variants.
Morris JA; Rahman JA; Guo X; Sanjana NE
iScience; 2021 Nov; 24(11):103380. PubMed ID: 35814872
[TBL] [Abstract][Full Text] [Related]
12. A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening.
Cirincione A; Simpson D; Ravisankar P; Solley SC; Yan J; Singh M; Adamson B
bioRxiv; 2024 Mar; ():. PubMed ID: 38585933
[TBL] [Abstract][Full Text] [Related]
13. Interpreting functional effects of coding variants: challenges in proteome-scale prediction, annotation and assessment.
Shameer K; Tripathi LP; Kalari KR; Dudley JT; Sowdhamini R
Brief Bioinform; 2016 Sep; 17(5):841-62. PubMed ID: 26494363
[TBL] [Abstract][Full Text] [Related]
14. Functional Genetic Variants Revealed by Massively Parallel Precise Genome Editing.
Sharon E; Chen SA; Khosla NM; Smith JD; Pritchard JK; Fraser HB
Cell; 2018 Oct; 175(2):544-557.e16. PubMed ID: 30245013
[TBL] [Abstract][Full Text] [Related]
15. High-throughput CRISPRi and CRISPRa technologies in 3D genome regulation for neuropsychiatric diseases.
Jones IR; Ren X; Shen Y
Hum Mol Genet; 2022 Oct; 31(R1):R47-R53. PubMed ID: 35972825
[TBL] [Abstract][Full Text] [Related]
16. A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing.
Saber Sichani A; Ranjbar M; Baneshi M; Torabi Zadeh F; Fallahi J
Mol Biotechnol; 2023 Jun; 65(6):849-860. PubMed ID: 36547823
[TBL] [Abstract][Full Text] [Related]
17. Search-and-replace genome editing without double-strand breaks or donor DNA.
Anzalone AV; Randolph PB; Davis JR; Sousa AA; Koblan LW; Levy JM; Chen PJ; Wilson C; Newby GA; Raguram A; Liu DR
Nature; 2019 Dec; 576(7785):149-157. PubMed ID: 31634902
[TBL] [Abstract][Full Text] [Related]
18. Genome scale analysis of pathogenic variants targetable for single base editing.
Lavrov AV; Varenikov GG; Skoblov MY
BMC Med Genomics; 2020 Sep; 13(Suppl 8):80. PubMed ID: 32948190
[TBL] [Abstract][Full Text] [Related]
19. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
Geurts MH; de Poel E; Pleguezuelos-Manzano C; Oka R; Carrillo L; Andersson-Rolf A; Boretto M; Brunsveld JE; van Boxtel R; Beekman JM; Clevers H
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34373320
[TBL] [Abstract][Full Text] [Related]
20. Prime editing: advances and therapeutic applications.
Zhao Z; Shang P; Mohanraju P; Geijsen N
Trends Biotechnol; 2023 Aug; 41(8):1000-1012. PubMed ID: 37002157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
